Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$16.13 - $44.61 $13,613 - $37,650
-844 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$40.23 - $47.74 $1,367 - $1,623
-34 Reduced 3.87%
844 $37,000
Q4 2021

Feb 08, 2022

BUY
$38.88 - $45.31 $1,321 - $1,540
34 Added 4.03%
878 $39,000
Q3 2021

Nov 05, 2021

BUY
$38.79 - $43.16 $659 - $733
17 Added 2.06%
844 $32,000
Q2 2020

Aug 06, 2020

BUY
$37.87 - $43.58 $8,596 - $9,892
227 Added 37.83%
827 $34,000
Q2 2019

Aug 08, 2019

SELL
$39.4 - $42.7 $4,097 - $4,440
-104 Reduced 14.77%
600 $24,000
Q4 2018

Feb 06, 2019

SELL
$37.8 - $42.69 $10,508 - $11,867
-278 Reduced 28.31%
704 $27,000
Q3 2018

Nov 06, 2018

SELL
$39.75 - $42.69 $79,778 - $85,678
-2,007 Reduced 67.15%
982 $39,000
Q2 2018

Aug 21, 2018

BUY
$39.61 - $42.76 $4,753 - $5,131
120 Added 4.18%
2,989 $120,000
Q1 2018

May 14, 2018

BUY
$36.18 - $40.15 $40,051 - $44,446
1,107 Added 62.83%
2,869 $112,000
Q4 2017

Feb 15, 2018

BUY
$35.34 - $41.9 $3,145 - $3,729
89 Added 5.32%
1,762 $62,000
Q3 2017

Nov 15, 2017

BUY
$39.44 - $41.55 $65,983 - $69,513
1,673
1,673 $67,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.